Navigation Links
AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders' Equity Requirement
Date:1/14/2008

implemented.

About Signalife, Inc.

Signalife, Inc. is a life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. Signalife, Inc. is the recipient of the Frost & Sullivan Technological Innovation Award for 2006.

Signalife, Inc. is traded on the American Stock Exchange under the symbol SGN. More information is located at http://www.signalife.com.

Caution Regarding Forward-Looking Statements

In this news release we make a number of statements, referred to as "forward-looking statements", which are intended to convey our expectations or predictions regarding the occurrence of possible future events or the existence of trends and factors that may impact our future plans and operating results. Any statements in this news release that are not statements of historical fact maybe considered to be forward-looking statements. These forward-looking statements are derived, in part, from various assumptions and analyses we have made in the context of our current business plan and information currently available to us and in light of our experience and perceptions of historical trends, current conditions and expected future developments and other factors we believe to be appropriate in the circumstances. You can generally identify forward-looking statements through words and phrases such as "seek", "anticipate", "believe", "estimate", "expect", "intend", "plan", "budget", "project", "may be", "may continue", "may likely result", and similar expressions. Each forward-looking statement should be read in context with, and with an understanding of, the various other disclosures concerning our company and our business made in this news release as w
'/>"/>

SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Signalife Provides Corporate Update
2. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
3. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
4. Signalife Achieves $1.98 Million Sales Orders Thus Far
5. Signalife Receives Another $3.3 Million Sales Orders
6. NFL Hall of Fame Legend Fred Biletnikoff Joins AFL/Signalife Cardiovascular Protection Team
7. Signalife Continues to Procure Purchase Orders, Revenues
8. Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device
9. U.S. Patent 7,299,083 Awarded to Signalife
10. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
11. Tapestry Receives Notice Regarding Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015  New Jersey Health Foundation, ... in the state of New Jersey ... of grant funding, announced James M. Golubieski , ... Foundation Research Grants program, an additional $500,000 will be ... fund early stage research projects that demonstrate exciting potential ...
(Date:3/30/2015)... - A new national Labour Market Information (LMI) report ... of new graduates entering the biotech sector. The BioTalent ... New Grads in Biotech," is sponsored in part by ... and features data collected from new graduates that participated ... 2013 to 2015. Among the interesting trends ...
(Date:3/30/2015)... USA (PRWEB) March 29, 2015 A ... the United States and plenary talks by four leading ... SPIE Optics + Optoelectronics next month in Prague, ... presentations in 17 conferences alongside a two-day exhibition. Sponsored ... photonics , the event will run 13-16 April in ...
(Date:3/30/2015)... Richmond Pharmacology nimmt weltweit ... ist das erste Zentrum weltweit, das in Zusammenarbeit ... in London in einer ... an einem Patienten begonnen hat. Das Therapeutikum wurde ... (ATTR), einer seltenen Herz- und Nervenkrankheit. ...
Breaking Biology Technology:New Jersey Health Foundation Announces An Additional $1 Million To Fund Innovation and Research Grants in New Jersey 2New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 2New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 3New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3
... 6%; Clinical Diagnostics Grows 9.4%; On Target to ... Achieve Full Year ... BEC ), a leading developer, manufacturer and marketer of,products that simplify, ... 30, 2007 results. Total,revenue of $669 million was up 6.0% over ...
... The University of Texas at San Antonio and The ... research universities in a nationwide consortium awarded $1.4 million ... Research Team (NIRT) grant is designed to explore ways ... and develop means of controlling optical energy for applications ...
... Pharmaceuticals,Inc. (Nasdaq: AMLN ) will be presenting at ... 9:30 a.m. PT in San Diego. Daniel M.,Bradbury, President ... a corporate overview. The live presentation will be ... event. The webcast and recording will be accessible,through Amylin,s ...
Cached Biology Technology:Beckman Coulter Announces Third Quarter 2007 Results 2Beckman Coulter Announces Third Quarter 2007 Results 3Beckman Coulter Announces Third Quarter 2007 Results 4Beckman Coulter Announces Third Quarter 2007 Results 5Beckman Coulter Announces Third Quarter 2007 Results 6Beckman Coulter Announces Third Quarter 2007 Results 7Beckman Coulter Announces Third Quarter 2007 Results 8Beckman Coulter Announces Third Quarter 2007 Results 9Beckman Coulter Announces Third Quarter 2007 Results 10Beckman Coulter Announces Third Quarter 2007 Results 11Beckman Coulter Announces Third Quarter 2007 Results 12Beckman Coulter Announces Third Quarter 2007 Results 13Beckman Coulter Announces Third Quarter 2007 Results 14Beckman Coulter Announces Third Quarter 2007 Results 15Beckman Coulter Announces Third Quarter 2007 Results 16Beckman Coulter Announces Third Quarter 2007 Results 17Beckman Coulter Announces Third Quarter 2007 Results 18Beckman Coulter Announces Third Quarter 2007 Results 19Beckman Coulter Announces Third Quarter 2007 Results 20Beckman Coulter Announces Third Quarter 2007 Results 21Beckman Coulter Announces Third Quarter 2007 Results 22Beckman Coulter Announces Third Quarter 2007 Results 23Beckman Coulter Announces Third Quarter 2007 Results 24Beckman Coulter Announces Third Quarter 2007 Results 25UTSA/UT lead national nanoscience consortium 2
(Date:3/11/2015)... and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) has announced ... Product, Application & By Geography - Global Forecast & ... This report predicts that the access control ... with an estimated CAGR of 10.6%. The ... as contact cards & readers, contactless cards & readers, ...
(Date:3/10/2015)...   Tute Genomics , pioneer in affordable, accurate ... sequencing company PrimBio Research Institute to be ... panel interpretation. PrimBio, a certified Life Technologies ... technologies to support the work of experts on the ... types of exome sequencing services: 1) Targeted Exome and ...
(Date:3/3/2015)... LAKE FOREST, Calif. , March 3, ... ("Company"), the leading provider of advanced cryogenic ... serving markets including immunotherapies, stem cells, cell ... health, and reproductive medicine, today announced the ... Hutchinson Cancer Research Centers, ("Fred Hutch") ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... will look at possible health effects of the Gulf of ... volunteers begins today in towns across Louisiana, Mississippi, Alabama, and ... is the largest health study of its kind ever conducted ... a comprehensive federal response to the Deepwater Horizon oil spill. ...
... in Temple University,s College of Science and Technology has ... leptin receptor antagonist peptide, developed by researchers Laszlo Otvos ... triple negative breast cancer treatment, especially in the obese ... in the European Journal of Cancer . ...
... Benjamin Clough has developed a novel method ... plasma acoustic bursts. The doctoral student at Rensselaer ... employs sound waves to boost the distance from ... remotely detect hidden explosives, chemicals, and other dangerous ...
Cached Biology News:NIH launches largest oil spill health study 2New peptide could be effective treatment for triple negative breast cancer 2Student innovation at Rensselaer holds key to safer remote detection of dangerous materials 2Student innovation at Rensselaer holds key to safer remote detection of dangerous materials 3
This issue concentrated on the purification of proteins for specific purposes (i.e. large-scale purification, purification for therapeutic use, etc.)...
Edited by D.M. Gersten (1996) Provides comprehensive descriptions of the techniques available for analytical gel electrophoresis of proteins and offers clear step-by-step protocols for all of the m...
... Walker (1996) • This book offers ... studying proteins and peptides. Each tried ... instruction, timesaving troubleshooting tips, alternative procedures, ... reagents and suppliers. Topics covered range ...
...
Biology Products: